H

Huons Co Ltd
KOSDAQ:243070

Watchlist Manager
Huons Co Ltd
KOSDAQ:243070
Watchlist
Price: 28 300 KRW -2.41% Market Closed
Market Cap: 339B KRW

EV/EBITDA
Enterprise Value to EBITDA

6.1
Current
6.3
Median
12.8
Industry
Lower than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
6.1
=
Enterprise Value
382.7B KRW
/
EBITDA
63.1B KRW
EBITDA Growth EV/EBITDA to Growth
KR
H
Huons Co Ltd
KOSDAQ:243070
Average EV/EBITDA: 395.2
6.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
37.5
30%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
12.7
7%
1.8
DK
Novo Nordisk A/S
CSE:NOVO B
15.1
13%
1.2
CH
Roche Holding AG
SIX:ROG
9.7
5%
1.9
CH
Novartis AG
SIX:NOVN
10.7
5%
2.1
UK
AstraZeneca PLC
LSE:AZN
131.4
10%
13.1
US
Merck & Co Inc
NYSE:MRK
8.8
8%
1.1
IE
E
Endo International PLC
LSE:0Y5F
261.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
2%
3.8

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
4.1
2-Years Forward
EV/EBITDA
3.8
3-Years Forward
EV/EBITDA
N/A